This inventor holds 3 USPTO granted patents. Top assignee: Tufts University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Wei Qiu: Innovator in Adiponectin Receptor Agonists
Introduction
Wei Qiu is a prominent inventor based in Boston, MA. He has made significant contributions to the field of medical research, particularly in the treatment of inflammation and bone diseases associated with diabetes. With a total of 3 patents to his name, his work is paving the way for innovative therapeutic approaches.
Latest Patents
Wei Qiu's latest patents focus on the use of adiponectin receptor agonists. These patents disclose methods for utilizing these agonists to treat inflammation and bone loss in subjects suffering from diabetes. His research highlights the potential of adiponectin receptor agonists in addressing critical health issues.
Career Highlights
Wei Qiu is affiliated with Tufts College, where he continues to advance his research. His work is characterized by a commitment to improving health outcomes through innovative solutions. His contributions to the field have garnered attention and respect from peers and the scientific community.
Collaborations
Wei collaborates with esteemed colleagues, including Jinkun Chen and Qisheng Tu. Their combined expertise enhances the research efforts and fosters a collaborative environment for innovation.
Conclusion
Wei Qiu's work in the development of adiponectin receptor agonists represents a significant advancement in medical research. His dedication to addressing inflammation and bone diseases in diabetes showcases the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile